Modeling in pharmacoeconomic studies: Funding sources and outcomes

International Journal of Technology Assessment in Health Care 2010), 26: 330-333

Abstract

Conclusions:
The review found a substantial share of studies supported by the pharmaceutical industry, almost all concluding in favor of the drug studied, without any unfavorable conclusions at all. These results confirm also in the field of pharmacoeconomic studies that the best way of limiting confounding factors is by clearly distinguishing assessors from manufacturers and marketers of any new technology.